摘要
Tertiary lymphoid structures(TLS)often develop at sites of persistent inflammation,including cancers and autoimmune diseases.In most cases,the presence of TLS correlates with active immune responses.Because of their proximity to pathological loci,TLS are an intriguing target for the manipulation of immune responses.For several years,it has become clear that lymphotoxin(LT)signalling plays critical roles in lymphoid tissue organogenesis and maintenance.In the current review,we will discuss the role of LT signalling in the development of TLS.With a focus on cancers and autoimmune diseases,we will highlight the correlations between TLS and disease progression.We will also discuss the current efforts and potential directions for manipulating TLS for immunotherapies.
基金
by the US National Institutes of Health through National Cancer Institute grants CA141975 and CA97296,CPRIT grant RR150072,grants from the Chinese Academy of Sciences(XDA09030303)
grants from the Chinese Ministry of Science and Technology(2012ZX10002006,2011DFA31250 and 2012AA020701)to YXF and a Cancer Resarch Institute Irvington Fellowship to HT.
